| Literature DB >> 19712485 |
Eva Warensjö1, Magdalena Rosell, Mai-Lis Hellenius, Bengt Vessby, Ulf De Faire, Ulf Risérus.
Abstract
Fatty acid composition of serum lipids and adipose tissue triacylglycerols (AT-TAG) partly reflect dietary fatty acid intake. The fatty acid composition is, besides the diet, also influenced by desaturating enzymes that can be estimated using product-to-precursor fatty acid ratios. The interrelationships between desaturase indices derived from different serum lipid fractions and adipose tissue are unclear, as well as their associations with obesity and insulin resistance. We aimed to investigate cross-sectional correlations between desaturase indices as measured in serum lipid fractions (phospholipids; PL and free fatty acids; FFA) and in adipose tissue (AT-TAG). In a population-based sample of 301 healthy 60-year-old men various desaturase indices were assessed: stearoyl-CoA-desaturase (16:1n-7/16:0; SCD-16 and 18:1n-9/18:0; SCD-18, respectively), delta-6-desaturase (20:3n-6/18:2n-6; D6D) and delta-5-desaturase (20:4n-6/20:3n-6; D5D). Correlations with BMI and insulin resistance (HOMA-IR) were also examined. SCD-16 and D5D were significantly correlated between fractions and tissues (all r > 0.30), whereas SCD-18 and D6D were not. Desaturase indices in serum FFA and AT-TAG were significantly correlated; SCD-16 (r = 0.63), SCD-18 (r = 0.37), and D5D (r = 0.43). In phospholipids, SCD-16 was positively correlated to BMI (r = 0.15), while D5D negatively to both BMI (r = -0.30) and HOMA-IR (r = -0.31), all p < 0.01. D6D in both phospholipids and AT-TAG was positively correlated to HOMA-IR and BMI (all p < 0.01). In conclusion, SCD-1 and D5D activity indices showed overall strong correlations between lipid pools. SCD-1 activity index in adipose tissue is best reflected by 16:1/16:0-ratio in serum FFA, but associations with obesity and insulin resistance differ between these pools. D5D in PL was inversely related to obesity and insulin resistance, whereas D6D index showed positive associations.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19712485 PMCID: PMC2746208 DOI: 10.1186/1476-511X-8-37
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Baseline characteristics of the study subjects.
| Baseline characteristics | N | |
| Age (years) | 63 (0.7) | 301 |
| BMI (kg/m2) | 25.9 (3.1) | 301 |
| Total cholesterol (mmol/l) | 5.9 (1.0) | 301 |
| LDL-cholesterol (mmol/l) | 3.7 (1.0) | 301 |
| HDL-cholesterol | 1.6 (1.4–1.8) | 301 |
| Triacylglycerol | 1.1 (0.8–1.4) | 301 |
| Fasting insulin | 5.8 (4.2–8.0) | 301 |
| Fasting glucose | 4.9 (4.6–5.2) | 301 |
| HOMA-IR | 1.3 (0.9–1.8) | 300 |
| Tobacco users (%) | 23 | 301 |
| Adipose tissue desaturase indices | ||
| SCD-16 | 0.36 (0.1) | 297 |
| SCD-18 | 14.8 (3.6) | 297 |
| D6D | 17(14–20) × 10-3 | 286 |
| D5D | 2.5 (0.6) | 286 |
| Free fatty acid desaturase indices | ||
| SCD-16 | 0.15 (0.04) | 300 |
| SCD-18 | 3.95 (0.73) | 300 |
| D6D | 33 (23–55) × 10-3 | 51 |
| D5D | 3.1 (2.2–4.1) | 51 |
| Phospholipid desaturase indices | ||
| SCD-16 | 0.02 (0.017–0.023) | 299 |
| SCD-18 | 0.94 (0.12) | 299 |
| D6D | 0.15(0.13–0.18) | 299 |
| D5D | 3.0 (0.71) | 299 |
Mean and standard deviation are presented for normally distributed variables and median and interquartile range (25th–75th percentiles) for skewed variables.
Skewed variable
HOMA Homeostasis model insulin resistance
SCD Stearoyl-CoA-desaturase (SCD-16 = 16:1(n-7)/16:0, SCD-18 = 18:1(n-9)/18:0)
D5D delta-5-desaturase (20:4(n-6)/20:3 (n-6))
D6D delta-6-desaturase (20:3(n-6)/18:2 (n-6))
Spearman rank correlations between estimated fatty acid desaturases in serum phospholipids, serum free fatty acids and adipose tissue triacylglycerols.
| Serum free fatty acids | Adipose tissue triacylglycerols | ||||||
| r | n | r | n | ||||
| SCD-16 | PL | 0.54 | 0.000 | 299 | 0.39 | 0.000 | 295 |
| FFA | - | - | - | 0.63 | 0.000 | 296 | |
| r | n | r | n | ||||
| SCD-18 | PL | 0.17 | 0.004 | 299 | -0.05 | 0.44 | 295 |
| FFA | - | - | - | 0.37 | 0.000 | 296 | |
| r | n | r | n | ||||
| D6D | PL | -0.13 | 0.44 | 39 | 0.53 | 0.000 | 295 |
| FFA | - | - | - | -0.06 | 0.69 | 48 | |
| r | n | r | n | ||||
| D5D | PL | 0.31 | 0.03 | 50 | 0.36 | 0.000 | 284 |
| FFA | - | - | - | 0.43 | 0.002 | 48 | |
SCD Stearoyl-CoA-desaturase (SCD-16 = 16:1(n-7)/16:0, SCD-18 = 18:1(n-9)/18:0)
D5D delta-5-desaturase (20:4(n-6)/20:3 (n-6))
D6D delta-6-desaturase 20:3(n-6)/18:2 (n-6)
PL Serum phospholipids
FFA serum free fatty acids
TAG Triacylglycerols
Figure 1Scatter plot showing the relation between SCD-16 (16:1/16:0) estimated in free fatty acids (FFA, x-axis) and adipose tissue triacylglycerols (TAG, y-axis).
Spearman rank correlations between estimated desaturase activities in serum phospholipids and adipose tissue triacylglycerols and clinical variables.
| BMI | HOMA- IR | ||||||
| r | n | r | n | ||||
| SCD-16 | PL | 0.15 | 0.009 | 299 | 0.08 | 0.17 | 298 |
| FFA | 0.08 | 0.18 | 300 | -0.16 | 0.006 | 299 | |
| AT-TAG | 0.17 | 0.004 | 297 | -0.02 | 0.78 | 296 | |
| SCD-18 | PL | -0.31 | 0.000 | 299 | -0.41 | 0.000 | 298 |
| FFA | 0.15 | 0.009 | 300 | 0.05 | 0.40 | 299 | |
| AT-TAG | 0.35 | 0.000 | 297 | 0.24 | 0.000 | 296 | |
| D6D | PL | 0.36 | 0.000 | 299 | 0.32 | 0.01 | 298 |
| FFA | -0.13 | 0.37 | 51 | -.0002 | 1.0 | 51 | |
| AT-TAG | 0.36 | 0.000 | 297 | 0.34 | 0.000 | 296 | |
| D5D | PL | -0.30 | 0.000 | 299 | -0.31 | 0.000 | 298 |
| FFA | 0.03 | 0.8 | 51 | -0.16 | 0.27 | 51 | |
| AT-TAG | 0.03 | 0.6 | 286 | -0.04 | 0.46 | 285 | |
SCD Stearoyl-CoA-desaturase (SCD-16 = 16:1(n-7)/16:0, SCD-18 = 18:1(n-9)/18:0)
D5D delta-5-desaturase (20:4(n-6)/20:3 (n-6))
D6D delta-6-desaturase (20:3(n-6)/18:2 (n-6)
PL Serum phospholipids
AT TAG adipose tissue triacylglycerols
BMI body mass index
HOMA IR Homeostasis model of insulin resistance